23andMe to go public, sparking fresh consumer DNA testing privacy fears
Genomics and biotechnology company 23andMe has announced that it is going public through a deal with Virgin. Under the deal,…
08 Feb 2021
50% of Brits support introduction of a vaccine passport
50% of Brits would support the idea of a vaccine passport, according to a survey by research company Piplsay. The concept of vaccine or immunity passports, e-certificates containing an individual’s…
14 Jan 2021
CTO Talk: Q&A with Exscientia’s Garry Pairaudeau
Dr Garry Pairaudeau is the CTO at Exscientia, a pharmatech company that uses artificial intelligence (AI) to accelerate drug discovery. Founded in 2012, the company combines its AI drug discovery…
12 Jan 2021
HealthHero acquires MyClinic to expand into Irish telehealth market
HealthHero has acquired rival telehealth company MyClinic.ie for an undisclosed sum as it continues its ambitious acquisition strategy. The strategic acquisition gives HealthHero a direct-to-consumer offering in Ireland. Previously it…
30 Nov 2020
DeepMind uses AI for breakthrough in “protein folding problem”
Artificial intelligence company DeepMind has solved a problem scientific researchers have faced for the past 50 years: protein folding. The “protein folding problem” refers to the shape in which proteins…
27 Oct 2020
MedCognition: How AR goggles are training first responders
Using Microsoft’s Hololens augmented reality (AR) goggles, medical technology startup MedCognition is aiming to improve training for first responders and reduce associated costs in the process. Emergency workers, such as…
22 Oct 2020
Human cells to be mass produced under “moonshot” biomedical partnership
A UK biomedical startup, bit.bio, has announced that it is partnering with the London Institute for Mathematical Science to code human cells and so pave way for them to be…